SBIR/STTR Research Award
Oral Smallpox Vaccine Development
Award amount
$428,289Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INCELL CORPORATION, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- G3XHRGRBCG25
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): This Phase I SBIR grant application aggressively targets the next steps in the development of lNCELL's oral smallpox vaccine. It builds on successful preliminary studies to develop the raw materials and do in vitro an
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ASSAY FOR MUTATIONS IN STEM CELLS AND THEIR DERIVATIVES
- Development of Gastrointestinal Transport Models
- DEVELOPMENT OF GASTROINTESTINAL TRANSPORT MODELS
- ADF--A NOVEL CYTOKINE INVOLVED IN ADIPOGENESIS
- FATTY ACID ENHANCEMENT OF CANCER THERAPY
Research funding history
7 SBIR/STTR records share this UEI (1998–2008). Reported award amounts total $1,303,309. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services